Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10

BACKGROUND: Interleukin-15 (IL-15) promotes growth and activation of cytotoxic CD8(+) T and natural killer (NK) cells. Bioactive IL-15 is produced in the body as a heterodimeric cytokine, comprising the IL-15 and IL-15 receptor alpha chains (hetIL-15). Several preclinical models support the antitumo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Immunother Cancer
Главные авторы: Bergamaschi, Cristina, Pandit, Hrishikesh, Nagy, Bethany A, Stellas, Dimitris, Jensen, Shawn M, Bear, Jenifer, Cam, Maggie, Valentin, Antonio, Fox, Bernard A, Felber, Barbara K, Pavlakis, George N
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Basic Tumor Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7254133/
https://ncbi.nlm.nih.gov/pubmed/32461349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000599
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы